Al-Mohaimeed Mansour M
Department of Ophthalmology, College of Medicine, Qassim University, Qassim, Kingdom of Saudi Arabia.
Clin Ophthalmol. 2022 Aug 25;16:2813-2822. doi: 10.2147/OPTH.S375587. eCollection 2022.
This study investigated the effect of prophylactic mitomycin C (MMC) on corneal endothelium to inhibit corneal haze formation post transepithelial photorefractive keratectomy (T-PRK).
A total of 120 eyes of 60 patients with low, moderate, and high myopia were subjected to T-PRK with intraoperative application of MMC (0.02%) for 30-50s. Patients' files were categorized into three groups according to ablation depths (if ≥100 µm) during T-PRK as follows: (1) Group A - low myopia without MMC, (2) Group B - low myopia with MMC, and (3) Group C - moderate/high myopia with MMC. Preoperative/surgical parameters and refractive outcomes were documented. Cell density (CD), number of cells (NUM), coefficient of variation, central corneal thickness (CCT), hexagonality (HEX/6A), average cell area (AVG), and its standard deviation (SD) were evaluated using specular microscopy preoperatively and postoperatively.
Overall, 119 out of 120 eyes showed significant prevention of corneal haze. Groups A and C showed no significant changes in endothelial CD and NUM. Group B showed a non-significant reduction in CD. However, all three groups showed significant variations in HEX/6A, CCT, AVG, and SD.
The MMC application did not significantly affect corneal endothelial density or number and can be used safely and effectively to prevent corneal haze following T-PRK in myopia.
本研究探讨预防性使用丝裂霉素C(MMC)对角膜内皮的影响,以抑制经上皮准分子激光角膜切削术(T-PRK)后角膜 haze 的形成。
60例低、中、高度近视患者共120只眼接受T-PRK手术,术中应用MMC(0.02%)30-50秒。根据T-PRK期间的消融深度(如果≥100 µm)将患者档案分为三组,如下:(1)A组 - 无MMC的低度近视,(2)B组 - 有MMC的低度近视,(3)C组 - 有MMC的中度/高度近视。记录术前/手术参数和屈光结果。术前和术后使用角膜内皮镜评估细胞密度(CD)、细胞数量(NUM)、变异系数、中央角膜厚度(CCT)、六角形细胞比例(HEX/6A)、平均细胞面积(AVG)及其标准差(SD)。
总体而言,120只眼中有119只眼的角膜 haze 得到了显著预防。A组和C组的角膜内皮CD和NUM无显著变化。B组的CD有非显著性降低。然而,所有三组的HEX/6A、CCT、AVG和SD均有显著变化。
应用MMC对角膜内皮密度或数量无显著影响,可安全有效地用于预防近视患者T-PRK术后的角膜 haze。